These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8083829)

  • 1. Interaction of HIV-1 and human salivary mucins.
    Bergey EJ; Cho MI; Blumberg BM; Hammarskjöld ML; Rekosh D; Epstein LG; Levine MJ
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):995-1002. PubMed ID: 8083829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
    Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
    Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1.
    Peacocke J; Lotz Z; de Beer C; Roux P; Mall AS
    Virol J; 2012 Aug; 9():177. PubMed ID: 22929306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts.
    Habte HH; de Beer C; Lotz ZE; Roux P; Mall AS
    Virol J; 2010 Oct; 7():269. PubMed ID: 20946627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale purification and characterization of the major phosphoproteins and mucins of human submandibular-sublingual saliva.
    Ramasubbu N; Reddy MS; Bergey EJ; Haraszthy GG; Soni SD; Levine MJ
    Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):341-52. PubMed ID: 1747107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
    Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
    Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative inhibitory potency of salivary mucins against human immunodeficiency virus type 1.
    McQuaid IK; Dorfman JR; Mall AS
    Virology; 2021 Jan; 553():1-8. PubMed ID: 33190061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of herpes simplex virus type 1 replication by human salivary secretions.
    Bergey EJ; Gu M; Collins AR; Bradway SD; Levine MJ
    Oral Microbiol Immunol; 1993 Apr; 8(2):89-93. PubMed ID: 8395041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product.
    Thornton DJ; Khan N; Mehrotra R; Howard M; Veerman E; Packer NH; Sheehan JK
    Glycobiology; 1999 Mar; 9(3):293-302. PubMed ID: 10024667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate.
    Edgerton M; Scannapieco FA; Reddy MS; Levine MJ
    Infect Immun; 1993 Jun; 61(6):2644-52. PubMed ID: 8500903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins.
    Iontcheva I; Oppenheim FG; Troxler RF
    J Dent Res; 1997 Mar; 76(3):734-43. PubMed ID: 9109822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-mediated protection against Helicobacter pylori is not associated with increased salivary cytokine or mucin expression.
    Ng GZ; Chionh YT; Sutton P
    Helicobacter; 2014 Feb; 19(1):48-54. PubMed ID: 24165046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.
    Nagashunmugam T; Malamud D; Davis C; Abrams WR; Friedman HM
    J Infect Dis; 1998 Dec; 178(6):1635-41. PubMed ID: 9815215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.
    Wickström C; Christersson C; Davies JR; Carlstedt I
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):421-8. PubMed ID: 11023828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B.
    Nielsen PA; Bennett EP; Wandall HH; Therkildsen MH; Hannibal J; Clausen H
    Glycobiology; 1997 Apr; 7(3):413-9. PubMed ID: 9147051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human glandular salivas: their separate collection and analysis.
    Veerman EC; van den Keybus PA; Vissink A; Nieuw Amerongen AV
    Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):346-52. PubMed ID: 8930581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis of glandular parotid and submandibular-sublingual saliva in comparison to whole human saliva by two-dimensional gel electrophoresis.
    Walz A; Stühler K; Wattenberg A; Hawranke E; Meyer HE; Schmalz G; Blüggel M; Ruhl S
    Proteomics; 2006 Mar; 6(5):1631-9. PubMed ID: 16402355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.